Sequenom mentioned positively at Wedbush

Wedbush has learned that Sequenom competitors Natera & Ariosa have received letters from the New York Department of Health ordering the companies to stop processing tests coming from the State, which would be a positive for Sequenom. Shares are Outperform rated with a $5 price target.

View Comments (0)